glp-1 weight loss drug news today 2025 How Supply and Demand for Drugs is Playing Out in 2026 Weight-loss drug makers announce pricing
Description
Cignarelli, F
Alzheimers disease
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): A multicentre, randomised, placebo-controlled trial
doi:10.1093/micmic/ozad102 Mieczkowska A, Millar P, Chappard D, Gault VA, Mabilleau G
The absence of randomized controlled trials, limited long-term developmental follow-up, and regional healthcare variations warrant caution
